Selegiline transdermal (Emsam) is a monoamine oxidase inhibitor delivered through a skin patch for major depressive disorder in adults. The delivery route changes exposure compared with oral selegiline used for Parkinson’s disease.

Mechanism and mnemonic
“YosEmite Sam Seals gills” connects Emsam with selegiline. The Mao Zedong cue on the patch recalls monoamine oxidase inhibition. The pegged decagon ballicule illustrates its pharmacology.

Interactions and formulation cautions
The interaction avatar illustrates CYP2B6 substrate metabolism. Serious pharmacodynamic interactions remain important, including serotonin toxicity with contraindicated serotonergic medications.
Tyramine dietary restrictions depend on patch strength and recent treatment changes. Drug-specific washout intervals are required when changing interacting medications.
